NCT00355758终止不适用
Prostate Cancer Detection by Serum Proteomic Profiling
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 200
- 试验地点
- 1
研究概览
简要总结
: Researchers would like to see if a new test called SELDI (Surface Enhanced Laser Desorption Ionization) analysis can predict biopsy results better than PSA tests.
详细描述
A blood sample of approximately 30 cc will be collected prior to the patients standard of care radical prostatectomy surgery. This blood will be used for the SELDI analysis. The remainder of the blood sample will be stored and may be used for the PSA test at a later date. The patient will have a final blood draw 3 months to 1 year following surgery.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •For all subjects:
- •Men 50 years of age or older.
- •Serum PSA greater than or equal to 2.5 ng/ml and less then or equal to 10.0 ng/ml determined by a measurement within the past six months, and/or digital rectal exam suspicious for prostate cancer as determined by the patient's Urologist.
- •It has been determined by the treating physician that a prostate biopsy is clinically indicated.
- •Patients will have already been diagnosed with prostate cancer and scheduled for a radical prostatectomy.
- •For study on treatment effect
- •Men with clinically localized prostate cancer (total PSA < 20 ng/ml and clinical T2b or less).
- •Men with organ confined prostate cancer as determined by final pathologic diagnosis.
排除标准
- •Exclusion criteria for all subjects:
- •Known prostate cancer or prior treatment for prostate cancer.
- •Acute prostatitis.
- •Untreated urinary tract infection.
- •Presence of Foley catheter or any urethral instrumentation in the previous 48 hours.
- •Hormonal therapies including LHRH agonists, oral anti-androgens, estrogenic compounds, Proscar or any phytotherapies within the previous 6 months.
- •Exclusion Criteria (for study on treatment effect)
- •Men with non-organ confined prostate cancer.
- •Men with detectable serum PSA levels more than 1 months following radical prostatectomy.
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Detection of Early Lung Cancer by Serum Protein Expression ProfilingNon-small Cell Lung CancerNCT00175578University of British Columbia220
尚未招募
不适用
Predicting Prostate Cancer in Elderly MenProstate Cancer (Diagnosis)NCT04079699Odense University Hospital700
已完成
不适用
Biparametric MRI for Detection of Significant Prostate CancerProstate CancerNCT02584179Herlev Hospital1,063
已完成
不适用
Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerElevated Prostate Specific Antigen (PSA)Prostate CancerNCT00773773Memorial Sloan Kettering Cancer Center500
Unknown
不适用
Analysis of a New Biomarker for Prostate Cancer DiagnosisPatients With Suspected Prostate CancerNCT01819740Corporacion Parc Tauli28